[한국보건산업진흥원, 의사과학자 글로벌 공동연구지원] 혈관성 뇌변성 정밀 치료표적 발굴 글로벌 다중 플랫폼 융합연구, 핵심 참여교수, [2025.10 ~ 2029.12]
[한국보건산업진흥원, K-Medi 융합인재 양성 지원사업] 한국인 알츠하이머치매 환자유래 직접교차분화 신경세포, 교세포 활용 세포노화 관련 치료타겟 발굴 및 신약재창출에 관한 연구, 연구책임자 [2024.4 ~ 2026.12]
[질병관리청 국립보건연구원 바이오뱅크과, 혁신형 바이오뱅킹 컨소시엄 지원사업] 혁신형 만성뇌혈관질환 바이오뱅킹 컨소시엄 구축사업, 실무교수, [2021.3 ~ 2025.12]
[한국보건산업진흥원] 환자 유래 섬유아세포 및 다중 오믹스 자료 활용을 통한 알츠하이머병 병리기전 및 치료 타겟 발굴에 관한 연구, 연구책임자, [2022.4 ~ 2023.12]
[Korea Health Industry Development Institute (KHIDI), Global Physician-Scientist Collaborative Research Program] Precision Therapeutic Target Discovery for Vascular Neurodegeneration: A Global Multi-Platform Integrative Study, Core Participating Professor, [Oct 2025 ~ Dec 2029]
[Korea Health Industry Development Institute (KHIDI), K-Medi Convergence Talent Development Program] Discovery of Senescence-Related Therapeutic Targets and Drug Repositioning Using Directly Converted Neurons and Glial Cells Derived from Korean Patients with Alzheimer’s Disease, Principal Investigator, [Apr 2024 ~ Dec 2026]
[Korea Disease Control and Prevention Agency (KDCA), National Institute of Health (KNIH), Division of Biobank – Innovative Biobanking Consortium Support Program] Establishment of an Innovative Chronic Cerebrovascular Disease Biobanking Consortium, Operational Professor, [Mar 2021 ~ Dec 2025]
[Korea Health Industry Development Institute (KHIDI)] Discovery of Pathological Mechanisms and Therapeutic Targets for Alzheimer’s Disease Using Patient-Derived Fibroblasts and Multi-Omics Data, Principal Investigator, [Apr 2022 ~ Dec 2023]
Our research examines the role of cellular senescence in Alzheimer’s disease. Using direct conversion of patient-derived fibroblasts, we generate neurons that capture individual aging signatures and compare these features with clinical, neuroimaging, and proteomic data. We also investigate senescence in microglia and other glial populations to better understand how aging across different cell types may contribute to neurodegenerative vulnerability. Through these approaches, we aim to clarify senescence-related mechanisms in Alzheimer’s disease and explore potential avenues for therapeutic development.
This project aims to investigate how endothelial cells and microglia contribute to vascular neurodegeneration. Using patient-derived and control iPSC models, we will examine differential cellular responses to vascular neurodegeneration related perturbations, enabling us to capture patient-specific vulnerability that cannot be observed in conventional systems. Single-cell RNA sequencing will be used to map early transcriptional and functional changes along disease-relevant pathways. Through these comparisons, we hope to identify mechanisms that link vascular dysfunction, inflammation, and neuronal injury, guiding future efforts in biomarker and therapeutic development.
(No graduate student role for cohort management) The BICWALZS cohort, led by Principal Investigator Chang Hyung Hong, is a core clinical platform optimized for research in Alzheimer’s disease and vascular neurodegeneration. Hyun Woong Roh contributes to the practical aspects of cohort management, including cross-sectional and longitudinal data collection, clinical phenotyping, neuroimaging, and biospecimen coordination across approximately 1,300 participants, along with a biobanking of more than 250 patient-derived fibroblasts and over 30 iPSC lines. This integrated resource supports patient-specific modeling and provides a strong foundation for translational research, biomarker discovery, and mechanistic studies in aging-related cognitive disorders.